Trial · NCT01253421
Participant flow45
How many started, completed or left each group, period by period.
1 to 20 of 45
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Assessment and Scheduling | STARTED | All Participants Prior to Randomization | 159 | |
| Assessment and Scheduling | STARTED | MDD-amisulpride | 0 | |
| Assessment and Scheduling | STARTED | MDD-placebo | 0 | |
| Assessment and Scheduling | STARTED | HC-amisulpride | 0 | |
| Assessment and Scheduling | STARTED | HC-placebo | 0 | |
| Assessment and Scheduling | Eligible After Screening Visit | All Participants Prior to Randomization | 85 | |
| Assessment and Scheduling | Eligible After Screening Visit | MDD-amisulpride | 0 | |
| Assessment and Scheduling | Eligible After Screening Visit | MDD-placebo | 0 | |
| Assessment and Scheduling | Eligible After Screening Visit | HC-amisulpride | 0 | |
| Assessment and Scheduling | Eligible After Screening Visit | HC-placebo | 0 | |
| Assessment and Scheduling | Returned for Drug+Scanning Visit | All Participants Prior to Randomization | 60 | |
| Assessment and Scheduling | Returned for Drug+Scanning Visit | MDD-amisulpride | 0 | |
| Assessment and Scheduling | Returned for Drug+Scanning Visit | MDD-placebo | 0 | |
| Assessment and Scheduling | Returned for Drug+Scanning Visit | HC-amisulpride | 0 | |
| Assessment and Scheduling | Returned for Drug+Scanning Visit | HC-placebo | 0 | |
| Assessment and Scheduling | COMPLETED | All Participants Prior to Randomization | 60 | |
| Assessment and Scheduling | COMPLETED | MDD-amisulpride | 0 | |
| Assessment and Scheduling | COMPLETED | MDD-placebo | 0 | |
| Assessment and Scheduling | COMPLETED | HC-amisulpride | 0 | |
| Assessment and Scheduling | COMPLETED | HC-placebo | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01253421/flow